Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2015-06-25
2015-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Moreover, the prone position is often considered as uncomfortable by the patients. However, there is few publications in the literature on breast MRI in decubitus position.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
NCT02956473
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
NCT06370234
Use of Compressed Sensing in Breast MRI
NCT02826369
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
NCT01433640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supine position
3.0 tesla MRI in supine position
Position for the 3.0 Tesla in Magnetic Resonance Imaging
Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.
This examination is then extended by 10 minutes without additional injection of contrast medium
Prone position
3.0 tesla MRI in prone position
Position for the 3.0 Tesla in Magnetic Resonance Imaging
Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.
This examination is then extended by 10 minutes without additional injection of contrast medium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Position for the 3.0 Tesla in Magnetic Resonance Imaging
Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.
This examination is then extended by 10 minutes without additional injection of contrast medium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Assessment on 3.0 Tesla in Magnetic Resonance Imaging
* Age \>18 years old
* ECOG performance status ≤ 3
* Ability to provide written informed consent form
Exclusion Criteria
* Claustrophobia
* Contraindication to the injection of contrast medium Gadoline
* Contraindication to MRI
* Persons deprived of liberty or under supervision
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Cancérologie de Lorraine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
OLDRINI GUILLAUME, MD
Role: PRINCIPAL_INVESTIGATOR
Institut de Cancérologie de Lorraine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00578-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.